At the beginning of the year, PharmaVOICE asked the question: Over the past 15 years the life-sciences industry has undergone a tremendous transformation, in your perspective what has been the biggest change in terms of your area of expertise or company’s focus?
Jay Lichter, Ph.D. responded:
“The biggest change in venture investing over the last 15 years has been expanded scientific innovation. To capitalize on these opportunities, we realized we needed to streamline the process of creating new biotechs that could quickly find, validate and translate new technologies into medical advances.
One of the major handicaps for a new biotech is the “starting up,” so we created COI Pharmaceuticals, a community of innovation that provides operational support, mentorship, and a fully equipped R&D facility. This has created a pipeline of companies pursuing early-stage discovery across various therapy areas.”
See the full article and additional responses here.
The post PharmaVOICE: 15 Year Reflections and Predictions appeared first on COI Pharma.